In contrast to breast cancer, Liu et al. (2022) analyzed an RNA-sequencing database and found that the expression of NFE2L3 in liver cancer was positively correlated with tumor grade and stage, and analysis of clinical patient tissue samples also revealed a significant association between high NFE2L3 levels and poor prognosis in patients with liver cancer. This evidence concerns the gene NFE2L3 and breast carcinoma.